Zentalis Pharmaceuticals
$43.219876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$43.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.79 (+6.90%) As of 5:17 PM UTC today
Why Robinhood?
You can buy or sell ZNTL and other stocks, options, and ETFs commission-free!
About ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock, also called Zentalis Pharmaceuticals, is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer.
CEO
Anthony Y. Sun
Employees
124
Headquarters
New York, New York
Founded
2014
Market Cap
1.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
332.87K
High Today
$44.25
Low Today
$40.32
Open Price
$40.39
Volume
367.97K
52 Week High
$61.29
52 Week Low
$23.28
ZNTL Earnings
-$2.88
-$1.92
-$0.96
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 14, Pre-Market